Yissum - Research Development Company of the Hebrew University

Moebius Medical

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Investment Opportunities in Startups and Spinoffs · Israel

Summary of the technology

Moebius Medical
Project ID : 6-2013-2902

Yissum - Research Development Company of the Hebrew University

Description of the technology

Liposomes as a Novel Bio-lubricant for Osteoarthritic Joints

Investment/ Collaboration Opportunity Highlights:

Having recently completed a successful proof-of-concept clinical trial, at December 2012, the company plans to launch a pivotal clinical study in 2013 and expects to have CE and FDA regulatory approval by Q3 2014. The requested investment amount of $5M will enable the company to conclude the coming clinical trial and to submit a market approval request to the EU. and US. authorities.

About the company

The company was founded in 2008 under the auspices of the RAD BioMed Accelerator. The company’s IP was developed by a multidisciplinary team from the Hebrew University of Jerusalem, the Technion Institute of Technology, and Hadassah.

Our products

Moebius Medical is developing the MM-II, a novel bio-lubricant that provides long-term effect by using liposomes as mechanical lubricants. Having completed a 40-subject clinical study, the MM-II shows great promise as the next-generation bio-lubricant for OA joints. Thanks to the special and unique consistency of liposomes, this innovative technology reduces joint damage and deterioration through the use of “biological ball-bearings” that provide mechanical lubrication, ease cartilage surface gliding, prevent further cartilage wear & tear, and eliminate additional joint damage and deterioration.

  • Extended duration of therapeutic effect compared to existing solutions
  • Prevents further cartilage wear & tear
  • Comprised of FDA approved compounds
  • Accelerated regulatory path due to characterization as a medical device (not a drug)

Development Milestones

Moebius Medical has conducted a successful proof-of-concept clinical trial at Hadassah Medical Center.

Contact details

Dr. Yaniv Dolev, CEO

yaniv@moebiusmedical.com

+972-52-8911618

www.moebiusmedical.com

Project manager

Shoshana Keynan
VP, Head of Business Development, Healthcare

Project researchers

Yechezkel Barenholz
HUJI, Faculty of Medicine
Biochemistry

Related keywords

  • Medicine, Human Health
  • Biology / Biotechnology
  • Genome Research
  • Micro- and Nanotechnology related to Biological sciences
  • Medical Research
  • Recombinant DNA
  • Monoclonal Antibodies and Hybridomas
  • Gene Splicing and Manufacturing Equipment
  • Other Genetic Engineering
  • Molecular design Market
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Toxicology Market
  • In vitro Testing, Trials Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Population genetics Market
  • Gene Expression, Proteom Research Market
  • Bioinformatics Market
  • Enzymology/Protein Engineering/Fermentation
  • Genetic Engineering Market
  • Clinical Medicine
  • Anatomy, Pathology, Immunology, Physiology
  • Agro and Marine biotech
  • Other Medical/Health Related
  • Therapeutic
  • Diagnostic
  • Other ( Clinical Medicine related )
  • Life Science & Biotechnology
  • Bone / Cartilage

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.